THE Therapeutic Goods Administration (TGA) has advised of anticipated shortages of Creon 25,000 unit and Creon 35,000 unit capsules between 21 Aug and 31 Dec 2025, due to an unexpected global increase in demand.

The sponsor, Viatris, will continue to receive a regular supply of all strengths of Creon (pancreatic extract), but availability may be limited and may vary from one pharmacy to another during this period.

Pharmacists are urged to dispense no more than a month’s supply of Creon at a time; to ask patients not to stockpile the product; and to suggest patients contact them in advance to organise their next prescription, to ensure that Creon is available when they need it.

Learn more HERE.

The post Creon shortage anticipated appeared first on Pharmacy Daily.